Starck Daniel J
SEC CIK 1345856 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ACH | ACCENDRA HEALTH INC/VA/ | EVP, Pres Patient Direct, CEO of Apria | 95.6K | — | — | 5 | 2022-05-10 | 2024-05-15 |
Most active insiders at ACH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Galloway Heath H | EVP, GC, CorpSecy | — | — |
| 2 | Bernocchi Perry A | EVP, COO | — | — |
| 3 | Gardner-Smith Kenneth | Dir | — | — |
| 4 | Klemash Stephen W | Dir | — | — |
| 5 | Leon Jonathan A | EVP, CFO | — | — |
| 6 | Long Andrew G | EVP, CEO P, HS | — | — |
| 7 | Kline Teresa L. | Dir | — | — |
| 8 | Beck Mark A | Dir | — | — |
| 9 | Pesicka Edward A | Pres, CEO, Dir | — | — |
Starck Daniel J made no open-market trades at ACH in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-16 | 2024-05-15 | ACH | ACCENDRA HEALTH INC/VA/ | Starck Daniel J | EVP, Business Excellence | F - Tax | $19.78 | -9,446 | 95.6K | -9% | -$186.8K | |
| 2024-03-05 | 2024-03-01 | ACH | ACCENDRA HEALTH INC/VA/ | Starck Daniel J | EVP, Business Excellence | A - Grant | $0.00 | +33.0K | 105.1K | +46% | $0 | |
| 2023-05-17 | 2023-05-15 | ACH | ACCENDRA HEALTH INC/VA/ | Starck Daniel J | EVP, Business Excellence | F - Tax | $18.73 | -2,139 | 72.1K | -3% | -$40.1K | |
| 2023-03-03 | 2023-03-01 | ACH | ACCENDRA HEALTH INC/VA/ | Starck Daniel J | EVP, Business Excellence | A - Grant | $0.00 | +52.6K | 74.2K | +244% | $0 | |
| 2022-05-11 | 2022-05-10 | ACH | ACCENDRA HEALTH INC/VA/ | Starck Daniel J | EVP, Pres Patient Direct, CEO of Apria | A - Grant | $0.00 | +21.6K | 21.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations